The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Theraputics Inc. (ACRS) | COM | 00461U105 | 8,857 | 634,455 | SH | SOLE | 634,455 | 0 | 0 | ||
Aeglea Biotherapeutics Inc. (AGLE) | COM | 00773J103 | 854 | 1,691,151 | SH | SOLE | 1,691,151 | 0 | 0 | ||
Atreca Inc. (BCEL) | CL A COM | 04965G109 | 694 | 387,653 | SH | SOLE | 387,653 | 0 | 0 | ||
AVROBIO, Inc. (AVRO) | COM | 05455M100 | 929 | 1,009,779 | SH | SOLE | 1,009,779 | 0 | 0 | ||
Biomea Fusion Inc. (BMEA) | COM | 09077A106 | 9,569 | 798,757 | SH | SOLE | 798,757 | 0 | 0 | ||
BridgeBio Pharma Inc. (BBIO) | COM | 10806X102 | 55,099 | 6,068,125 | SH | SOLE | 6,068,125 | 0 | 0 | ||
Elevation Oncology Inc. (ELEV) | COM | 28623U101 | 3,969 | 2,834,910 | SH | SOLE | 2,834,910 | 0 | 0 | ||
Marker Therapeutics, Inc. (MRKR) | COM | 57055L107 | 1,037 | 3,142,857 | SH | SOLE | 3,142,857 | 0 | 0 | ||
Monte Rosa Therapeutics Inc. (GLUE) | COM | 61225M102 | 14,237 | 1,472,331 | SH | SOLE | 1,472,331 | 0 | 0 | ||
Nabriva Therapeutics plc (NBRV) | SHS | G63637113 | 16 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
Nuvation Bio Inc. (NUVB) | COM CL A | 67080N101 | 8,233 | 2,541,009 | SH | SOLE | 2,541,009 | 0 | 0 | ||
Poseida Therapeutics Inc. (PSTX) | COM | 73730P108 | 2,692 | 1,043,267 | SH | SOLE | 1,043,267 | 0 | 0 | ||
Viracta Therapeutics Inc. (VIRX) | COM | 92765F108 | 1,120 | 288,571 | SH | SOLE | 288,571 | 0 | 0 | ||
Verona Pharma plc (VRNA) | SPONSORED ADS | 925050106 | 5,583 | 1,332,485 | SH | SOLE | 1,332,485 | 0 | 0 | ||
Zosano Pharma Corporation (ZSAN) | COM NEW | 98979H202 | 24 | 77,663 | SH | SOLE | 77,663 | 0 | 0 | ||
Reneo Pharmaceuticals Inc. (RPHM) | COM | 75974E103 | 2,348 | 886,075 | SH | SOLE | 886,075 | 0 | 0 | ||
Syndax Pharmaceuticals, Inc. (SNDX) | COM | 87164F105 | 19,721 | 1,025,000 | SH | SOLE | 1,025,000 | 0 | 0 | ||
Spruce Biosciences, Inc. (SPRB) | COM | 85209E109 | 2,098 | 1,205,511 | SH | SOLE | 1,205,511 | 0 | 0 | ||
Talaris Therapeutics Inc. (TALS) | COM | 87410C104 | 3,080 | 682,923 | SH | SOLE | 682,923 | 0 | 0 |